Literature DB >> 29301655

Intrathecal antibody responses to GalC in Guillain-Barré syndrome triggered by Mycoplasma pneumoniae.

Patrick M Meyer Sauteur1, Ruth Huizinga2, Anne P Tio-Gillen3, Judith Drenthen4, Wendy W J Unger5, Enno Jacobs6, Annemarie M C van Rossum5, Bart C Jacobs7.   

Abstract

Mycoplasma pneumoniae (Mp) triggers Guillain-Barré syndrome (GBS) and elicits anti-galactocerebroside (GalC) antibodies. Specifically anti-GalC IgG is associated with Mp-GBS, possibly because of its better ability to cross the blood-nerve barrier (BNB). We here investigated CSF for the presence of anti-GalC in GBS. Intrathecal anti-GalC was found in 46% of Mp-GBS patients (n=6/13), in contrast to 16% of GBS controls (n=4/25) and 0% of non-GBS controls (n=0/7). The antibodies most likely originated from increased BNB permeability and/or intrathecal synthesis. Intrathecal anti-GalC IgG was specifically associated with Mp-GBS, further supporting that anti-GalC IgG contributes to the pathogenesis of GBS.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Cerebrospinal fluid; Galactocerebroside (GalC); Guillain-Barré syndrome (GBS); Intrathecal synthesis; Mycoplasma pneumoniae

Mesh:

Substances:

Year:  2017        PMID: 29301655     DOI: 10.1016/j.jneuroim.2017.11.011

Source DB:  PubMed          Journal:  J Neuroimmunol        ISSN: 0165-5728            Impact factor:   3.478


  6 in total

Review 1.  Immunotherapy of Guillain-Barré syndrome.

Authors:  Shuang Liu; Chaoling Dong; Eroboghene Ekamereno Ubogu
Journal:  Hum Vaccin Immunother       Date:  2018-07-12       Impact factor: 3.452

2.  Mycoplasma pneumoniae triggers pneumonia epidemic in autumn and winter in Beijing: a multicentre, population-based epidemiological study between 2015 and 2020.

Authors:  Xue Wang; Maozhong Li; Ming Luo; Qin Luo; Lu Kang; Hui Xie; Yiting Wang; Xiali Yu; Aihua Li; Mei Dong; Fang Huang; Cheng Gong
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

3.  Neurological Disorders Identified during Treatment of a SARS-CoV-2 Infection.

Authors:  Shinichi Wada; Yoji Nagasaki; Yoko Arimizu; Masatoshi Shimo; Yuta Matsukuma; Masaki Okamoto; Shinichiro Yoshida; Ikkei Ohashi; Go Hashimoto; Takahiro Kuwashiro; Masahiro Yasaka; Yasushi Okada
Journal:  Intern Med       Date:  2020-07-21       Impact factor: 1.271

Review 4.  Infection strategies of mycoplasmas: Unraveling the panoply of virulence factors.

Authors:  Chen Yiwen; Wu Yueyue; Qin Lianmei; Zhu Cuiming; You Xiaoxing
Journal:  Virulence       Date:  2021-12       Impact factor: 5.882

5.  Estimation of intrathecal IgG synthesis: simulation of the risk of underestimation.

Authors:  Mickael Bonnan; Mariana Gianoli-Guillerme; Henri Courtade; Stéphanie Demasles; Elsa Krim; Raluca Marasescu; Hervé Dréau; Stéphane Debeugny; Bruno Barroso
Journal:  Ann Clin Transl Neurol       Date:  2018-03-24       Impact factor: 4.511

Review 6.  Thrombosis associated with mycoplasma pneumoniae infection (Review).

Authors:  Jingwei Liu; Yumei Li
Journal:  Exp Ther Med       Date:  2021-07-07       Impact factor: 2.447

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.